European equities traded in the US as American depositary receipts opened the week on a flat note Monday morning, edging 0.08% higher to 1,835.34 on the S&P Europe Select ADR Index.
From continental Europe, the gainers were led by semiconductor company Sequans Communications (SQNS) and biopharmaceutical company Cellectis (CLLS), which advanced 8.1% and 6.3% respectively. They were followed by biopharmaceutical company DBV Technologies (DBVT) and telecommunications company Ericsson (ERIC), which increased 4.9% and 3.2% respectively.
The decliners from continental Europe were led by consumer goods company Unilever (UL) and biopharmaceutical company Grifols (GRFS), which fell 1.9% and 1.3% respectively. They were followed by internet browser company Opera (OPRA) and accommodations booking site trivago (TRVG), which were down 1% each.
The gainers from the UK were led by cruise line operator Carnival (CUK) and pharmaceutical company Silence Therapeutics (SLN), which rose 6.6% and 4.7% respectively. They were followed by biotech firm Autolus Therapeutics (AUTL) and biopharmaceutical company Amarin (AMRN), which were up 3.9% and 3.4% respectively.
The decliners from the UK and Ireland were led by biopharmaceutical companies Akari Therapeutics (AKTX) and Mereo BioPharma Group (MREO), which lost 10% and 7.3% respectively. They were followed by biopharmaceutical company Biodexa Pharmaceuticals (BDRX) and software firm Endava (DAVA), which dropped 5.8% and 2.2% respectively.